Activation systems in tissue culture toxicity studies

Toxicology
|January 1, 1982
PubMed

Insights

Metabolic activation, primarily by cytochrome P-450 enzymes, generates toxic metabolites. Understanding the balance of activation and inactivation pathways is crucial for assessing xenobiotic toxicity, especially in tissue culture studies.

Area of Science:

  • Toxicology
  • Drug Metabolism
  • Biochemistry

Background:

  • Xenobiotic toxicity is often mediated by active metabolites.
  • The cytochrome P-450-dependent microsomal mixed function oxidase (MFO) system is a key player in producing these metabolites.
  • Metabolic activation pathways are balanced by inactivation pathways, influencing the extent of toxicity.

Purpose of the Study:

  • To review the role of metabolic activation in xenobiotic toxicity.
  • To discuss the use and considerations of activation systems in tissue culture toxicity studies.
  • To evaluate different activation systems for their merits in toxicity assessment.

Main Methods:

  • Review of existing literature on xenobiotic metabolism and toxicity.
  • Discussion of various in vitro and in vivo activation systems.
  • Comparative analysis of different activation systems (whole animal, liver cells, microsomes).

Main Results:

  • Metabolic activation is a critical determinant of xenobiotic toxicity.
  • The liver is a primary site for xenobiotic activation, but extra-hepatic sites are also relevant.
  • Different activation systems provide complementary information for toxicity studies.

Conclusions:

  • Careful selection of activation systems is essential for accurate tissue culture toxicity studies, especially for organ-specific toxicity.
  • The choice of activation system should align with the study's objectives.
  • Utilizing multiple activation systems can yield comprehensive insights into xenobiotic toxicity.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...